March 31 (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.

Google-Backed AI Drug Discovery Startup Raises $600 Million (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

From Vemurafenib for treatment of late-stage melanoma approved back in 2011, to Capivasertib for treatment of breast cancer that was just approved November 2023, fragment-based drug discovery has ...

Isomorphic Labs was spun out of DeepMind in 2021 as a commercial venture, aiming to 'reimagine' the entire drug discovery process Isomorphic Labs, a subsidiary of Google parent Alphabet that uses ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

This is particularly true in biotechnology, where AI models power breakthroughs in drug discovery, precision medicine, gene editing, food security, and many other research areas. One sub-field is ...

and show that it can effectively treat infection through combined photodynamic–photothermal therapy without needing to consider drug resistance.

The drug menace has reached frightening proportions ... the movements of Mexico’s CJNG throughout Delhi-NCR, the discovery of their manufacturing facility in Gautam Buddha Nagar sent shockwaves ...